Once you are done with a clinical trial, the next line of action is usually to wait for the results to be published. The ways in which clinical trials are published depend upon ins and outs of clinical trials.
Some are made public and this notion is gaining traction since the benefits far outweigh the risks. A result that is made public may benefit a larger number of people who might not be a part of the specific process but are in the same field or people who are working in parallels.
A critical analysis is also preferred by the researchers so that the study is available of the new research that tells how it adds up with the existing information in the market.
Charities also publish the findings on their websites that they have funded.
Some organizations are a bit more secretive about their results and they just make the results and findings available for the people that took part. However this practice is slowly becoming a thing of the past. In these times, the trials are so well regulated and recorded that there is not much to gain by not going public.
After a trial has ended, the patients are reverted back to the standard treatments and drugs that are available in the market for mass use. If the patient feels that the treatment provided during the trial was helpful in any way, he/she can ask for the treatment to continue post trial. They will be required to buy the treatment on a private basis in some cases.
There is a question that comes across more often than not which is “Why isn’t the treatment made available immediately if the results have been positive?
The success of a clinical trial is also based on the finical viability. If a treatment goes way over budget, it won’t pass the test unless researchers come up with a way to decrease the costs and it becomes cost effective. This process can take some time.
In other cases, the compilation may take some time, or a delay might be due to many factors not known to the public. Participants are advocated to stay in touch with the officials or the correspondents.